stage iv breast cancer

Showing 51 - 75 of 167

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage IV Prostate Cancer, Stage IV Colon Cancer, Stage IV Breast Cancer Trial in Kingston (Dibenzyl trisulphide capsules, Stage

Unknown status
  • Stage IV Prostate Cancer
  • +3 more
  • Dibenzyl trisulphide capsules
  • +4 more
  • Kingston, Jamaica
    Faculty of Medial Sciences
Oct 3, 2019

Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Ramat-Gan, Lampang (BP-C1)

Completed
  • Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Ramat-Gan, Israel
  • +1 more
Oct 3, 2019

Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Thailand (BP-C1, Placebo)

Completed
  • Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Udon Thani, Udon Thani Province, Thailand
  • +3 more
Oct 3, 2019

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Akt Inhibitor GSK2141795,

Completed
  • Estrogen Receptor Negative
  • +6 more
  • Akt Inhibitor GSK2141795
  • +2 more
  • Washington, District of Columbia
  • +7 more
Aug 27, 2019

Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Chicago (cabergoline)

Completed
  • Recurrent Breast Cancer
  • Stage IV Breast Cancer
  • Chicago, Illinois
    Northwestern University
Sep 4, 2019

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, other, procedure, radiation,

Completed
  • Male Breast Cancer
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 15, 2019

Chemotherapeutic Agent Toxicity, Pain, Peripheral Neuropathy Trial in Chicago (cryotherapy, questionnaire administration,

Terminated
  • Chemotherapeutic Agent Toxicity
  • +11 more
  • cryotherapy
  • +4 more
  • Chicago, Illinois
    Northwestern University
Aug 16, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Male Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Houston (biological, drug, procedure, other)

Terminated
  • Male Breast Cancer
  • +4 more
  • oblimersen sodium
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 8, 2019

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)

Completed
  • Stage IA Breast Cancer
  • +6 more
  • educational intervention
  • +4 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 23, 2019

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

Recurrent Breast Carcinoma, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer Trial in United States (Akt Inhibitor MK2206,

Completed
  • Recurrent Breast Carcinoma
  • +3 more
  • Akt Inhibitor MK2206
  • +2 more
  • Boston, Massachusetts
  • +4 more
Nov 28, 2018

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)

Completed
  • Male Breast Cancer
  • +5 more
  • ONTAK
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Completed
  • Estrogen Receptor-negative Breast Cancer
  • +5 more
  • paclitaxel albumin-stabilized nanoparticle formulation
  • +2 more
  • Anchorage, Alaska
  • +16 more
Nov 6, 2018

Breast Carcinoma Metastatic in the Bone, Circulating Tumor Cell Count, Estrogen Receptor Positive Trial in Chicago, Lake Forest

Terminated
  • Breast Carcinoma Metastatic in the Bone
  • +5 more
  • Denosumab
  • Laboratory Biomarker Analysis
  • Chicago, Illinois
  • +1 more
Oct 22, 2018

Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer Trial in Bronx (fulvestrant,

Completed
  • Estrogen Receptor-positive Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Oct 4, 2018

Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer Trial in Tucson

Completed
  • Estrogen Receptor-positive Breast Cancer
  • +4 more
  • therapeutic estradiol
  • +3 more
  • Tucson, Arizona
    University of Arizona Cancer Center
Sep 21, 2018

Estrogen Receptor Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Rochester (Alisertib,

Completed
  • Estrogen Receptor Positive
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 2, 2018

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago, Evanston (mifepristone, ,

Completed
  • Male Breast Cancer
  • +5 more
  • Chicago, Illinois
  • +1 more
Sep 10, 2018

Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (drug, other, procedure)

Terminated
  • Cardiovascular Complications
  • +7 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 30, 2018

Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in New Orleans, Winston-Salem (biological, drug, procedure)

Terminated
  • Breast Cancer
  • +2 more
  • panitumumab
  • +4 more
  • New Orleans, Louisiana
  • +1 more
Jul 3, 2018

Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)

Completed
  • Stage I Breast Cancer
  • +5 more
  • questionnaire administration
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

Hyaluronic Acid in Causing Cancer Stem Cell Growth in Bones of

Withdrawn
  • Breast Carcinoma Metastatic to the Bone
  • Stage IV Breast Cancer
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jun 29, 2018